Profound Medical (PROF) Net Cash Flow Growth (1y) (2025 - 2026)

Profound Medical (PROF) Net Cash Flow Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -53.07%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 17.60%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 10.50%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -564.44%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -31.84%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -394.13%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 76.43%
10 Profound Medical 266.61 Mn 216.31 Mn 3.83 Mn -0.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.12%
Dec 31, 2025 17.95%
Sep 30, 2025 -29.60%
Jun 30, 2025 -101.47%
Mar 31, 2025 -153.83%